IDO overexpression in tumor cells can inhibit the activation of T cells and the recruitment of regulatory T cells (Tregs) through the Kyn pathway by depleting Trp, leading to tumor proliferation and immune escape [9–12]. The gene discussed is IDO1; the disease is neoplasm.